Antiasthmatic drugs

Pirquinozol (SQ-13,847) is a drug which was investigated as an antiallergen and antiasthmatic agent in the early 1980s but was never marketed.

Salbutamol, also known as albuterol and marketed as Ventolin among other names, is a medication that opens up the medium and large airways in the lungs.

Pitrakinra (trade name Aerovant) is a 15-kDa human recombinant protein of wild-type human interleukin-4 (IL-4).

Hexoprenaline (HEX-oh-PREN-a-leen, INN) is a selective β2 adrenergic receptor agonist used in the treatment of asthma.

Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication.

Prednisone is a synthetic corticosteroid drug that is particularly effective as an immunosuppressant drug.

Tranilast (INN, brand name Rizaben) is an antiallergic drug.

Isoprenaline (INN) or isoproterenol (USAN) (trade names Medihaler-Iso and Isuprel) is a medication used for the treatment of bradycardia (slow heart rate), heart block, and rarely for asthma.

The combination preparation fluticasone/salmeterol is a formulation containing fluticasone propionate and salmeterol xinafoate, used in the management of asthma and chronic obstructive pulmonary disease (COPD).

Mometasone furoate is a glucocorticosteroid used topically to reduce inflammation of the skin or in the airways.

Omalizumab, sold under the trade name Xolair, is a humanized antibody originally designed to reduce sensitivity to inhaled or ingested allergens, especially in the control of moderate to severe allergic asthma, which does not respond to high doses of corticosteroids.

Fluticasone is a synthetic glucocorticoid.

Mometasone/formoterol is a combination inhaler containing both an inhaled corticosteroid and long-acting bronchodilator.

Reproterol (INN) is a short-acting β2 adrenoreceptor agonist used in the treatment of asthma.

Beclometasone dipropionate, also spelled beclomethasone dipropionate and sold under the brand name Qvar among others, is a steroid medication.

Fluticasone propionate belongs to a class of drugs known as corticosteroids, specifically glucocorticoids, which are hormones that predominantly affect the metabolism of carbohydrates and, to a lesser extent, fat and protein.

Fevipiprant (INN; code name QAW039) is a drug being developed by Novartis which acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2 or CRTh2).